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STuned using the frequency analyser (HM5014-2) to the corresponding Larmor
frequency of 64MHz for 1.5T MRI (GE, Signa), occluders were implanted into
a freshly excised porcine heart and Thiel soft embalmed human heart under MRI
guidance. 0.9% NaCl solution bath was used as the medium. Two MRI resonant
markers were placed on the delivery system to position the occluders with the right
orientation. Real time sequences were used for the visualization during the implan-
tation (MS, FGRE, TR¼10 ms-50 ms, TE¼2.4 ms-4 ms and small ﬂip angles of 15-30
with standard head coil). To keep the hearts in the right orientation, a holding device
made of acrylic plates was manufactured.
Results: The in-vitro test results showed a local image contrast enhancement of up to
4 times at low ﬂip angles of about 10-15. The locally improved contrast in the MR
images was relative homogenous and showed no artefacts. The MRI guided
implantation in both fresh porcine and Thiel soft embalmed human hearts was
successful. The MRI resonant markers on the delivery system enabled the correct
positioning of the occluders. An exact differentiation between the MR-Enhancing
implant and tissue were obtained in all views.
Conclusions: MRI guided implantation of occluders can be improved with resonant
circuits integrated into the design of the implant. The locally enhanced MRI signal
creates a better contrast between the tissue and the implant and enables accurate MRI
guided delivery, and non-invasive follow up examination.TCT-815
Positive Vascular Remodeling and Plaque Vulnerability: Biological Insights from
the Novel Familial Hypercholesterolemic Swine Model of Atherosclerosis
Masahiko Shibuya1, Armando Tellez1, Yanping Cheng1, Carlos A. Gongora1,
Athanasios Peppas1, Matthew Purdy1, Samantha G. Stone1, William Rate1,
Christian Krueger2, Dhanansayan Shanmuganayagam2, Greg L. Kaluza1,
Juan Granada1
1Cardiovascular Research Foundation, Orangeburg , NY, 2University of Wisconsin,
Madison, WI
Background: Pathology studies have shown correlation between positive vascular
remodeling and plaque characteristics in humans. In this study we aimed to correlate
the presence of in vivo vascular remodeling with the presence of histological features
of plaque vulnerability in the novel familial hypercholesterolemic swine (FHS) model
of atherosclerosis.
Methods: Fifteen naïve coronary arteries of 3-year-old FHS were imaged with
angiography and intravascular ultrasound (IVUS) to identify native plaques.
Remodeling index (RI) was deﬁned as the area of the external elastic lamina (EEL)
within the plaque divided by the EEL in the proximal reference by IVUS. Analyzed
plaques were allocated into positive (RI >1.0) and negative remodeling (RI  1.0)
categories. After imaging, coronaries were harvested and sectioned every 3-5 mm
intervals. Each section was stained with Movat's pentachrome stain and evaluated for
complex atherosclerotic features such as calciﬁcation, plaque hemorrhage and necrotic
core.
Results: Twenty three plaques were found and 43% (n¼10) displayed positive remod-
eling. Percent diameter of stenosis did not show signiﬁcant difference between plaques
with positive or negative remodeling (RI>1.0, 55.722.0 % versus RI1.0, 45.520.0
%, p¼0.3). Histological comparison revealed plaqueswith positive remodeling contained
higher incidence of necrotic core (RI>1.0, 90% versus RI1.0, 46.1% p¼0.03), necrotic
core area (RI>1.0, 2.230.6 mm2 versus RI1.0, 1.340.7 mm2, p¼0.03), and thinner
ﬁbrous cap (RI>1.0, 172102mmversusRI1.0, 312129mm,p¼0.023) thanplaques
with negative remodeling. Plaque hemorrhage (RI>1.0, 40 % versus RI 1.0, 0 %
p¼0.02) and calciﬁcation (RI>1.0, 60 % versus RI1.0, 15.3 % p¼0.03) was also more
frequently observed in plaques with positive remodeling.
Conclusions: The FHS model displays human-like vascular remodeling features.
Alike in humans, these features correlate to histopathological characteristics of plaque
vulnerability.TCT-816
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Background: Pre-clinical studies of transcatheter aortic valve implantation (TAVI)
systems have traditionally been conducted on surgically implanted valves in the mitral
position or on valves placed in the descending aorta. Very limited data exist on
orthotopic TAVI utilizing animal models.
Methods: Cardiac and aortic anatomy of juvenile-adolescent Dorset sheep was
determined with 3D reconstruction of CT-scan images. Animals with appropriateJACC Vol 62/18/Suppl B j October 27–November 1, 2013 j TCT Abstrmeasurements were selected for transfemoral TAVI with a 27mm Lotus Valve
System (Boston Scientiﬁc, Natick, US). Procedural guidance combined intracardiac
echocardiography (ICE) and ﬂuoroscopy. Valve performance was assessed at implant
(ICE) and 90 days (transthoracic echocardiography [TTE])
Results: Valve deployment was attempted on 15 animals. Successful implantation
with >72h survival was achieved in 80% of the cases (12/15). One sheep was
survived to 7 days, 3 to 30 days and 8 to 140 days (73% scheduled survival rate [11/
15]). Complete AV block was observed in 2 cases. Immediate post-implantation valve
evaluation revealed: no paravalvular leak (PVL) in 92% (12/13), mild PVL in one case
and normal function with a mean mean transvalvular gradient of 4.1 mmHg (range 1.2
to 7.7 mmHg). Ninety-day TTE showed a mean mean gradient of 29.1 mmHg (range
13.5 to 47.0 mmHg). Animals gained an average 5.1kg per month during follow-up.
Histology showed no endocarditis and minimal inﬂammation at 30 days (140 day data
pending).
Conclusions: Chronic survival rate in this non-diseased ovine model was excellent.
To our knowledge this represents the ﬁrst description of successful TAVI in the
native aortic position in a chronic animal study. The Lotus valve's fully reposi-
tionable design allowed precise positioning and provided adequate performance at
90 days. Adolescent and juvenile sheep are well-known models of accelerated
bioprostheses calciﬁcation which, combined with signiﬁcant animal growth, likely
explain the increase in mean gradient at follow-up. Long term (140 day) histology
will provide relevant insight on valve behaviour in this novel animal model of
orthotopic TAVI.TCT-817
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Background: Cardiac gene therapy represents one of the future therapeutic strategies
for cardiomyopathy but methods and measures of efﬁcacy vary widely. The aim of
this current study was to test an antegrade coronary approach for AAV9 delivery in
combination with vasodilators and concomitant retrograde blockage of the coronary
sinus in a pre-clinical large animal model.
Methods: The approach was tested in 14 chronically instrumented dogs which
received the vector intracoronarily. The left main coronary artery was cannulated with
a 5F EBU 3.5 or C1 catheter and a 2.5F micro-infusion catheter was selectively
advanced into the target vessel. The solution for infusion was prepared with 10^13
AAV9-GFP particles, saline, SubstanceP (0.25ng/kg/min) and Adenosine (0.15mg/kg/
min) and injected slowly over 20min. To further enhance endothelial penetration
nitrogycerine was given i.v. (1mg/kg/min). The coronary sinus was approached with
a custom made balloon in seven subjects which was inﬂated during the infusion.
Hemodynamic data were recorded during the procedure and infection efﬁcacy was
assessed using immunohistochemistry after 30days.
Results: The procedure was successful in all cases. Procedure time was signiﬁcantly
longer in the cases with coronary sinus occlusion (5812 vs. 9348min, p<0.05).
Mean arterial pressure (MAP) and dP/dtmax dropped in all cases (11617 to
4919mmHg and 2332487 to 1466454mmHg/sec) whereas the mean coronary
ﬂow increased from 146 to 187mL/min. These effects were enhanced with
coronary sinus blockage where infusion had to be discontinued during the procedure
several times in three cases due to hypotension (MAP 40mmHg11mmHg with and
599mmHg without coronary sinus blockage). The GFP-transduction rate was
heterogeneous within the myocardial layers (0.5-55%). There was no signiﬁcant
increase of GFP-expression caused by the additional coronary sinus blockage
(p¼0.08).
Conclusions: Antegrade intracoronary gene delivery is feasible, comparatively
effective and can be enhanced with vasodilators. The addition of coronary sinus
blockage during infusion increases the complexity and risk of the procedure in some
cases and might not be translatable for heart failure patients.TCT-818
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Background: Atherosclerosis seems to affect arteries in a site-speciﬁc pattern.
Remodeling processes, frequency of acute thrombotic complications and restenosis-
rates differ in various vascular beds. For a better understanding of site-speciﬁc
differences we analyzed plaque morphology and gene expression in femoral, carotid
and coronary arteries.
Methods: Coronary vessels were obtained from 16 patients with coronary artery
disease, carotid arteries from 10 and femoral arteries from 9 patients with
peripheral occlusive disease (PAD). Microscopic sections were analyzed blindly onacts/POSTER/Basic Science, Animal Models, and Cell Therapy B247
